Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02851784 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma

Name: Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma — clinical trial record (NCT02851784)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2/3

SponsorChinese PLA General Hospital

Started2009-12

View on ClinicalTrials.gov ↗

Chinese PLA General Hospital

193 trials monitored

See 4 trials at risk

Liver Cancer

1,505 trials monitored

See 60 trials at risk

The study is to observe safety, survival effect and peripheral T-lymphocyte subsets of combination therapy with percutaneous microwave ablation (MWA) and adoptive immunotherapy in hepatocellular carcinoma(HCC).

Trial Details

NCT Number	NCT02851784
Lead Sponsor	Chinese PLA General Hospital
Conditions	Hepatocellular Carcinoma
Enrollment	80 participants
Start Date	2009-12
Primary Completion	2028-12-30 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-09-17